ReviewEndocrine, metabolic & immune disorders drug targets2026

Current Status and Future Prospects of Immune Checkpoint Inhibitors Research in the Treatment of Multiple Myeloma.

Xiaojia Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.